paxeladine 2 mg/ml
beaufour ipsen industrie - franta - oxeladinum - sirop - 2mg/ml - antitusive, excl.combinatii cu expectorante alte antitusive
smecta 3 g/plic
beaufour ipsen industrie - franta - diosmectita - pulb. pt. susp. orala - 3g/plic - adsorbante intestinale alte adsorbante intestinale
fortrans
beaufour ipsen industrie - franta - macrogolum - pulb. pt. sol. orala - laxative laxative osmotice
tanakan (egb 761) (n06dx02)
beaufour ipsen ind. - franta - ginkgo biloba - compr. film. - 40mg - vasodilatatoare periferice alte vasodilatatoare periferice
tanakan (egb 761) (n06dx02)
beaufour ipsen industrie - franta - ginkgo biloba - picaturi orale-sol. - 40mg/ml - vasodilatatoare periferice alte vasodilatatoare periferice
eziclen
beaufour ipsen industrie - franta - combinatii (sulfat de na+sulfat de mg+sulfat de k) - conc. pt. sol. orala - laxative laxative osmotice
diphereline pr 3 75 mg 3,75 mg pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită
ipsen pharma - triptorelinum - pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită - 3,75 mg
nutropinaq 10 mg/2 ml
ipsen pharma biotech sas - franta - somatropinum - sol. inj. - 10mg/2ml - hormoni ai lobului hipofizar anterior si analogi hormon somatotrop si agonisti ai acestuia
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - agenți antineoplazici - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
cometriq
ipsen pharma - cabozantinib - neoplasme tiroidiene - agenți antineoplazici - tratamentul pacienţilor adulţi cu progresivă, unresectable local avansat sau metastatic medular tiroidian carcinom.